New research demonstrates the potential of precise genome editing technologies, called adenine base editors, to correct disease-causing mutations in stem cells from patients with X-linked chronic ...
Dermatofibrosarcoma protuberans (DFSP) is a rare skin sarcoma known for its high recurrence rates, making treatment ...
The FISH testing market is booming, driven by its expanding role in diagnosing genetic disorders, personalizing cancer ...
For some proteins, a single mutation, or change in its DNA instructions, is all it takes to tip the balance between functioning normally and causing cancer.
Cardiovascular disease develops and presents differently in women and men. But medical guidelines are often based on studies ...
In the rapidly evolving landscape of personalized medicine, notable progress, especially in cancer research, has markedly ...
Scientists working with mice have zeroed in on the cells responsible for the most common and aggressive form of ovarian ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback